MeiG Smart Technology (002881.SZ) releases a forecasted increase in net profit for the year 2024, ranging from 112 million to 142 million yuan, a year-on-year growth of 73.62% to 120.12%.
Meg Intelligent (002881.SZ) released its performance forecast for the year 2024, expecting full-year attributable to shareholders of the listed company...
MeiG Smart Technology (002881.SZ) has released its performance forecast for 2024, expecting a net profit attributable to shareholders of the listed company of 1.12 billion yuan to 1.42 billion yuan for the full year, a year-on-year increase of 73.62% to 120.12%.
In 2024, the company's high computing power module products continue to expand their applications in the AI field, such as cloud servers, drones, machine vision, and humanoid robots from Siasun Robot & Automation, with rapidly increasing revenue from high computing power products. Shipments of 5G intelligent cockpit modules and vehicle-grade communication modules for smart cars, which integrate communication and computing, are experiencing rapid growth. Overseas business revenue continues to grow rapidly, mainly due to the sustained growth in demand for intelligent and customized products from overseas customers, as well as the increasing demand for 5G products from overseas operators.
Related Articles

HK Stock Market Move | In the morning session, Jiangsu Hengrui Pharmaceuticals (01276) rose nearly 7%, and its application for the listing permit of Rivaroxaban tablets was accepted by the European Medicines Agency (EMA).

HK Stock Market Move | INSILICO (03696) surged nearly 8% and reached a cooperation agreement with SK Biopharmaceuticals on AI-driven drug research and development. The potential total transaction amount exceeds $2.5 billion.

A-share Opening Express | Index Opening Low Shock Double Innovation Index Falls More Than 1% Innovative Drugs Concept Shock Lift
HK Stock Market Move | In the morning session, Jiangsu Hengrui Pharmaceuticals (01276) rose nearly 7%, and its application for the listing permit of Rivaroxaban tablets was accepted by the European Medicines Agency (EMA).

HK Stock Market Move | INSILICO (03696) surged nearly 8% and reached a cooperation agreement with SK Biopharmaceuticals on AI-driven drug research and development. The potential total transaction amount exceeds $2.5 billion.

A-share Opening Express | Index Opening Low Shock Double Innovation Index Falls More Than 1% Innovative Drugs Concept Shock Lift

RECOMMEND





